{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:13:36Z","timestamp":1794381216093,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":136,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642134425","type":"print"},{"value":"9783642134432","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-642-13443-2_20","type":"book-chapter","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T10:25:08Z","timestamp":1285064708000},"page":"483-507","source":"Crossref","is-referenced-by-count":22,"title":["Methylxanthines and Drug Dependence: A Focus on Interactions with Substances of Abuse"],"prefix":"10.1007","author":[{"given":"Micaela","family":"Morelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Simola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,19]]},"reference":[{"key":"20_CR1_20","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington","edition":"4"},{"key":"20_CR2_20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-540-69248-5_7","volume":"192","author":"J Barik","year":"2009","unstructured":"Barik J, Wonnacott S (2009) Molecular and cellular mechanisms of action of nicotine in the CNS. Handb Exp Pharmacol 192:173\u2013207","journal-title":"Handb Exp Pharmacol"},{"key":"20_CR3_20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0278-5846(98)00025-6","volume":"22","author":"VS Barwick","year":"1998","unstructured":"Barwick VS, Dar MS (1998) Adenosinergic modulation of ethanol-induced motor incoordination in the rat motor cortex. Prog Neuropsychopharmacol Biol Psychiatry 22:587\u2013607","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"20_CR4_20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0091-3057(98)00092-6","volume":"61","author":"JB Bedingfield","year":"1998","unstructured":"Bedingfield JB, King DA, Holloway FA (1998) Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacol Biochem Behav 61:291\u2013296","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR5_20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/bmj.298.6680.1075","volume":"298","author":"NL Benowitz","year":"1989","unstructured":"Benowitz NL, Hall SM, Modin G (1989) Persistent increase in caffeine concentrations in people who stop smoking. BMJ 298:1075\u20131076","journal-title":"BMJ"},{"key":"20_CR6_20","volume-title":"Coffee, tea chocolate and the brain","author":"D Benton","year":"2004","unstructured":"Benton D (2004) The biology and psychology of chocolate craving. In: Nehlig A (ed) Coffee, tea chocolate and the brain. CRC, Boca Raton"},{"key":"20_CR7_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(01)00181-8","volume":"66","author":"GA Bernstein","year":"2002","unstructured":"Bernstein GA, Carroll ME, Thuras PD et al (2002) Caffeine dependence in teenagers. Drug Alcohol Depend 66:1\u20136","journal-title":"Drug Alcohol Depend"},{"key":"20_CR8_20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.fbp.0000205014.67079.be","volume":"17","author":"A Bespalov","year":"2006","unstructured":"Bespalov A, Dravolina O, Belozertseva I et al (2006) Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists. Behav Pharmacol 17:295\u2013302","journal-title":"Behav Pharmacol"},{"key":"20_CR9_20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5993\/AJHB.31.5.3","volume":"31","author":"MD Blank","year":"2007","unstructured":"Blank MD, Kleykamp BA, Jennings JM et al (2007) Caffeine\u2019s influence on nicotine\u2019s effects in nonsmokers. Am J Health Behav 31:473\u2013483","journal-title":"Am J Health Behav"},{"key":"20_CR10_20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuint.2009.03.015","volume":"55","author":"CR Boeck","year":"2009","unstructured":"Boeck CR, Marques VB, Valvassori SS et al (2009) Early long-term exposure with caffeine induces cross-sensitization to methylphenidate with involvement of DARPP-32 in adulthood of rats. Neurochem Int 55:318\u2013322","journal-title":"Neurochem Int"},{"key":"20_CR11_20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.euroneuro.2008.01.002","volume":"18","author":"LA Briand","year":"2008","unstructured":"Briand LA, Flagel SB, Seeman P et al (2008) Cocaine self-administration produces a persistent increase in dopamine D2 High receptors. Eur Neuropsychopharmacol 18:551\u2013556","journal-title":"Eur Neuropsychopharmacol"},{"key":"20_CR12_20","first-page":"55","volume":"53","author":"CF Brice","year":"2002","unstructured":"Brice CF, Smith AP (2002) Factors associated with caffeine consumption. Int J Food Sci Nutr 53:55\u201364","journal-title":"Int J Food Sci Nutr"},{"key":"20_CR13_20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0899-3289(93)90056-H","volume":"5","author":"AJ Budney","year":"1993","unstructured":"Budney AJ, Higgins ST, Hughes JR et al (1993) Nicotine and caffeine use in cocaine-dependent individuals. J Subst Abuse 5:117\u2013130","journal-title":"J Subst Abuse"},{"key":"20_CR14_20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1476-5381.1982.tb09161.x","volume":"75","author":"JM Carney","year":"1982","unstructured":"Carney JM (1982) Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats. Br J Pharmacol 75:451\u2013454","journal-title":"Br J Pharmacol"},{"key":"20_CR15_20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0024-3205(85)90386-8","volume":"36","author":"JM Carney","year":"1985","unstructured":"Carney JM, Holloway FA, Modrow HE (1985) Discriminative stimulus properties of methylxanthines and their metabolites in rats. Life Sci 36:913\u2013920","journal-title":"Life Sci"},{"key":"20_CR16_20","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/sj.npp.1301375","volume":"32","author":"P Carriba","year":"2007","unstructured":"Carriba P, Ortiz O, Patkar K et al (2007) Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32:2249\u20132259","journal-title":"Neuropsychopharmacology"},{"key":"20_CR17_20","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/sj.npp.1300240","volume":"28","author":"O Cauli","year":"2003","unstructured":"Cauli O, Pinna A, Valentini V et al (2003) Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. Neuropsychopharmacology 28:1752\u20131759","journal-title":"Neuropsychopharmacology"},{"key":"20_CR18_20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pnpbp.2005.06.014","volume":"30","author":"E Celik","year":"2006","unstructured":"Celik E, Uzbay IT, Karakas S (2006) Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice. Prog Neuropsychopharmacol Biol Psychiatry 30:50\u201355","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"20_CR19_20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.taap.2003.08.002","volume":"193","author":"MH Chan","year":"2003","unstructured":"Chan MH, Chen HH (2003) Toluene exposure increases aminophylline-induced seizure susceptibility in mice. Toxicol Appl Pharmacol 193:303\u2013308","journal-title":"Toxicol Appl Pharmacol"},{"key":"20_CR20_20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.forsciint.2006.02.055","volume":"162","author":"JY Cheng","year":"2006","unstructured":"Cheng JY, Chan MF, Chan TW et al (2006) Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography-mass spectrometry. Forensic Sci Int 162:87\u201394","journal-title":"Forensic Sci Int"},{"key":"20_CR21_20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0091-3057(94)90297-6","volume":"47","author":"C Cohen","year":"1994","unstructured":"Cohen C, Pickworth WB, Bunker EB et al (1994) Caffeine antagonizes EEG effects of tobacco withdrawal. Pharmacol Biochem Behav 47:919\u2013936","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR23_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02247378","volume":"126","author":"SD Comer","year":"1996","unstructured":"Comer SD, Carroll ME (1996) Oral caffeine pretreatment produced modest increases in smoked cocaine self-administration in rhesus monkeys. Psychopharmacology 126:281\u2013285","journal-title":"Psychopharmacology"},{"key":"20_CR22_20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1037\/1064-1297.5.4.399","volume":"5","author":"SD Comer","year":"1997","unstructured":"Comer SD, Haney M, Foltin RW et al (1997) Effects of caffeine withdrawal on humans living in a residential laboratory. Exp Clin Psychopharmacol 5:399\u2013403","journal-title":"Exp Clin Psychopharmacol"},{"key":"20_CR24_20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1742-7843.2004.pto950509.x","volume":"95","author":"L Connole","year":"2004","unstructured":"Connole L, Harkin A, Maginn M (2004) Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination. Basic Clin Pharmacol Toxicol 95:299\u2013304","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"20_CR25_20","first-page":"183","volume":"95","author":"M Cooper","year":"2004","unstructured":"Cooper M, Safran M, Eberhardt M (2004) Caffeine consumption among adults on benzodiazepine therapy: United States 1988\u20131994. Psychol Rep 95:183\u2013191","journal-title":"Psychol Rep"},{"key":"20_CR26_20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1468-2982.1997.1703188.x","volume":"17","author":"EG Couturier","year":"1997","unstructured":"Couturier EG, Laman DM, van Duijn MA et al (1997) Influence of caffeine and caffeine withdrawal on headache and cerebral blood flow velocities. Cephalalgia 17:188\u2013190","journal-title":"Cephalalgia"},{"key":"20_CR27_20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.clpt.6100211","volume":"82","author":"RM Cysneiros","year":"2007","unstructured":"Cysneiros RM, Farkas D, Harmatz JS et al (2007) Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther 82:54\u201362","journal-title":"Clin Pharmacol Ther"},{"key":"20_CR28_20","first-page":"181","volume":"27","author":"I Dallard","year":"2001","unstructured":"Dallard I, Cathebras P, Sauron C et al (2001) Is cocoa a psychotropic drug? Psychopathologic study of a population of subjects self-identified as chocolate addicts. Encephale 27:181\u2013186","journal-title":"Encephale"},{"key":"20_CR29_20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0376-8716(98)00077-5","volume":"51","author":"JW Daly","year":"1998","unstructured":"Daly JW, Fredholm BB (1998) Caffeine\u2013an atypical drug of dependence. Drug Alcohol Depend 51:199\u2013206","journal-title":"Drug Alcohol Depend"},{"key":"20_CR30_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00690916","volume":"91","author":"MS Dar","year":"1987","unstructured":"Dar MS, Jones M, Close G et al (1987) Behavioral interactions of ethanol and methylxanthines. Psychopharmacology 91:1\u20134","journal-title":"Psychopharmacology"},{"key":"20_CR31_20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0022-3565(25)24014-9","volume":"271","author":"KT Delle Donne","year":"1994","unstructured":"Delle Donne KT, Sonsalla PK (1994) Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation. J Pharmacol Exp Ther 271:1320\u20131326","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR32_20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1471-4159.2007.04754.x","volume":"103","author":"MA Luca De","year":"2007","unstructured":"De Luca MA, Bassareo V, Bauer A et al (2007) Caffeine and accumbens shell dopamine. J Neurochem 103:157\u2013163","journal-title":"J Neurochem"},{"key":"20_CR33_20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00008877-200503000-00002","volume":"16","author":"RV Oliveira de","year":"2005","unstructured":"de Oliveira RV, Dall'Igna OP, Tort AB et al (2005) Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice. Behav Pharmacol 16:79\u201384","journal-title":"Behav Pharmacol"},{"key":"20_CR34_20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-4328(02)00286-3","volume":"137","author":"G Chiara Di","year":"2002","unstructured":"Di Chiara G (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 137:75\u2013114","journal-title":"Behav Brain Res"},{"key":"20_CR35_20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.npp.1300026","volume":"28","author":"CL Drake","year":"2003","unstructured":"Drake CL, Roehrs T, Turner L et al (2003) Caffeine reversal of ethanol effects on the multiple sleep latency test, memory, and psychomotor performance. Neuropsychopharmacology 28:371\u2013378","journal-title":"Neuropsychopharmacology"},{"key":"20_CR36_20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/10550490802019642","volume":"17","author":"RL Dupont","year":"2008","unstructured":"Dupont RL, Coleman JJ, Bucher RH et al (2008) Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict 17:167\u2013171","journal-title":"Am J Addict"},{"key":"20_CR37_20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0028-3908(03)00254-5","volume":"45","author":"M El Yacoubi","year":"2003","unstructured":"El Yacoubi M, Ledent C, Parmentier M et al (2003) Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology 45:977\u2013985","journal-title":"Neuropharmacology"},{"key":"20_CR38_20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.physbeh.2008.03.004","volume":"94","author":"A Enr\u00edquez-Castillo","year":"2008","unstructured":"Enr\u00edquez-Castillo A, Alamilla J, Barral J et al (2008) Differential effects of caffeine on the antidepressant-like effect of amitriptyline in female rat subpopulations with low and high immobility in the forced swimming test. Physiol Behav 94:501\u2013509","journal-title":"Physiol Behav"},{"key":"20_CR39_20","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.2007.05196.x","volume":"105","author":"S Ferr\u00e9","year":"2008","unstructured":"Ferr\u00e9 S (2008) An update on the mechanisms of the psychostimulant effects of caffeine. J Neurochem 105:1067\u20131079","journal-title":"J Neurochem"},{"key":"20_CR40_20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","volume":"20","author":"S Ferr\u00e9","year":"1997","unstructured":"Ferr\u00e9 S, Fredholm BB, Morelli M et al (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482\u2013487","journal-title":"Trends Neurosci"},{"key":"20_CR41_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1037\/1064-1297.11.1.9","volume":"11","author":"MT Fillmore","year":"2003","unstructured":"Fillmore MT (2003) Alcohol tolerance in humans is enhanced by prior caffeine antagonism of alcohol-induced impairment. Exp Clin Psychopharmacol 11:9\u201317","journal-title":"Exp Clin Psychopharmacol"},{"key":"20_CR42_20","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/0024-3205(88)90346-3","volume":"42","author":"IB Finn","year":"1988","unstructured":"Finn IB, Holtzman SG (1988) Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats. Life Sci 42:2475\u20132482","journal-title":"Life Sci"},{"key":"20_CR43_20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm BB, B\u00e4ttig K, Holm\u00e9n J et al (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83\u2013133","journal-title":"Pharmacol Rev"},{"key":"20_CR44_20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0379-0738(98)00102-9","volume":"95","author":"N Fucci","year":"1998","unstructured":"Fucci N, De Giovanni N (1998) Adulterants encountered in the illicit cocaine market. Forensic Sci Int 95:247\u2013252","journal-title":"Forensic Sci Int"},{"key":"20_CR45_20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(96)00435-2","volume":"57","author":"BE Garrett","year":"1997","unstructured":"Garrett BE, Griffiths RR (1997) The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacol Biochem Behav 57:533\u2013541","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR46_20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-3565(24)38755-5","volume":"296","author":"BE Garrett","year":"2001","unstructured":"Garrett BE, Griffiths RR (2001) Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers. J Pharmacol Exp Ther 296:486\u2013494","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR47_20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00213-002-1113-3","volume":"162","author":"M Gasior","year":"2002","unstructured":"Gasior M, Jaszyna M, Munzar P et al (2002) Caffeine potentiates the discriminative-stimulus effects of nicotine in rats. Psychopharmacology 162:385\u2013395","journal-title":"Psychopharmacology"},{"key":"20_CR48_20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0022-3565(24)38058-9","volume":"288","author":"M Gasior","year":"1999","unstructured":"Gasior M, Shoaib M, Yasar S et al (1999) Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther 288:1053\u20131073","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR49_20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1210\/endo-117-2-690","volume":"117","author":"SR George","year":"1985","unstructured":"George SR, Watanabe M, Di Paolo T et al (1985) The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology 117:690\u2013697","journal-title":"Endocrinology"},{"key":"20_CR50_20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-8993(93)91672-F","volume":"612","author":"V Georgiev","year":"1993","unstructured":"Georgiev V, Johansson B, Fredholm BB (1993) Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res 612:271\u2013277","journal-title":"Brain Res"},{"key":"20_CR51_20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1300\/J251v03n01_05","volume":"3","author":"K Gilliland","year":"1984","unstructured":"Gilliland K, Bullock W (1984) Caffeine: a potential drug of abuse. Adv Alcohol Subst Abuse 3:53\u201373","journal-title":"Adv Alcohol Subst Abuse"},{"key":"20_CR52_20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1037\/1064-1297.13.1.48","volume":"13","author":"KE Grattan-Miscio","year":"2005","unstructured":"Grattan-Miscio KE, Vogel-Sprott M (2005) Alcohol, intentional control, and inappropriate behavior: regulation by caffeine or an incentive. Exp Clin Psychopharmacol 13:48\u201355","journal-title":"Exp Clin Psychopharmacol"},{"key":"20_CR53_20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0893-133X(01)00343-8","volume":"26","author":"TA Green","year":"2002","unstructured":"Green TA, Schenk S (2002) Dopaminergic mechanism for caffeine-produced cocaine seeking in rats. Neuropsychopharmacology 26:422\u2013430","journal-title":"Neuropsychopharmacology"},{"key":"20_CR54_20","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0022-3565(25)23150-0","volume":"255","author":"RR Griffiths","year":"1990","unstructured":"Griffiths RR, Evans SM, Heishman SJ et al (1990) Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 255:1123\u20131132","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR55_20","volume-title":"Psychopharmacology: the fourth generation of progress","author":"RR Griffiths","year":"1995","unstructured":"Griffiths RR, Mumford GK (1995) Caffeine: a drug of abuse? In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York"},{"key":"20_CR56_20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.pnpbp.2007.02.006","volume":"31","author":"M Gurpegui","year":"2007","unstructured":"Gurpegui M, Jurado D, Luna JD et al (2007) Personality traits associated with caffeine intake and smoking. Prog Neuropsychopharmacol Biol Psychiatry 31:997\u20131005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"20_CR57_20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0091-3057(89)90075-0","volume":"32","author":"RD Harland","year":"1989","unstructured":"Harland RD, Gauvin DV, Michaelis RC et al (1989) Behavioral interaction between cocaine and caffeine: a drug discrimination analysis in rats. Pharmacol Biochem Behav 32:1017\u20131023","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR58_20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0149-7634(05)80202-7","volume":"16","author":"SJ Heishman","year":"1992","unstructured":"Heishman SJ, Henningfield JE (1992) Stimulus functions of caffeine in humans: relation to dependence potential. Neurosci Biobehav Rev 16:273\u2013287","journal-title":"Neurosci Biobehav Rev"},{"key":"20_CR59_20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0022-3565(25)23335-3","volume":"239","author":"SG Holtzman","year":"1986","unstructured":"Holtzman SG (1986) Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation. J Pharmacol Exp Ther 239:706\u2013714","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR60_20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3565(25)12929-7","volume":"277","author":"SG Holtzman","year":"1996","unstructured":"Holtzman SG (1996) Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines. J Pharmacol Exp Ther 277:739\u2013746","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR61_20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00001756-199101000-00013","volume":"2","author":"BA Horger","year":"1991","unstructured":"Horger BA, Wellman PJ, Morien A et al (1991) Caffeine exposure sensitizes rats to the reinforcing effects of cocaine. Neuroreport 2:53\u201356","journal-title":"NeuroReport"},{"key":"20_CR62_20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-009-1461-3","volume":"204","author":"CW Hsu","year":"2009","unstructured":"Hsu CW, Chen CY, Wang CS et al (2009a) Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice. Psychopharmacology 204:313\u2013325","journal-title":"Psychopharmacology"},{"key":"20_CR63_20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1742-7843.2009.00382.x","volume":"104","author":"HR Hsu","year":"2009","unstructured":"Hsu HR, Mei YY, Wu CY et al (2009b) Behavioural and toxic interaction profile of ketamine in combination with caffeine. Basic Clin Pharmacol Toxicol 104:379\u2013383","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"20_CR64_20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1037\/0033-2909.95.2.301","volume":"95","author":"J Istvan","year":"1984","unstructured":"Istvan J, Matarazzo JD (1984) Tobacco, alcohol, and caffeine use: a review of their interrelationships. Psychol Bull 95:301\u2013326","journal-title":"Psychol Bull"},{"key":"20_CR65_20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.brainresbull.2005.02.024","volume":"65","author":"R Jain","year":"2005","unstructured":"Jain R, Holtzman SG (2005) Caffeine induces differential cross tolerance to the amphetamine-like discriminative stimulus effects of dopaminergic agonists. Brain Res Bull 65:415\u2013421","journal-title":"Brain Res Bull"},{"key":"20_CR66_20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s002130050766","volume":"140","author":"M Jaszyna","year":"1998","unstructured":"Jaszyna M, Gasior M, Shoaib M et al (1998) Behavioral effects of nicotine, amphetamine and cocaine under a fixed-interval schedule of food reinforcement in rats chronically exposed to caffeine. Psychopharmacology 140:257\u2013271","journal-title":"Psychopharmacology"},{"key":"20_CR67_20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00213-002-1262-4","volume":"165","author":"HE Jones","year":"2003","unstructured":"Jones HE, Griffiths RR (2003) Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers. Psychopharmacology 165:280\u2013290","journal-title":"Psychopharmacology"},{"key":"20_CR68_20","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0022-3565(25)39453-X","volume":"266","author":"GB Kaplan","year":"1993","unstructured":"Kaplan GB, Greenblatt DJ, Kent MA et al (1993) Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. J Pharmacol Exp Ther 266:1563\u20131572","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR69_20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(01)00718-X","volume":"412","author":"M Khalili","year":"2001","unstructured":"Khalili M, Semnanian S, Fathollahi Y (2001) Caffeine increases paragigantocellularis neuronal firing rate and induces withdrawal signs in morphine-dependent rats. Eur J Pharmacol 412:239\u2013245","journal-title":"Eur J Pharmacol"},{"key":"20_CR70_20","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1164\/ajrccm.151.6.7767539","volume":"151","author":"J Kidney","year":"1995","unstructured":"Kidney J, Dominguez M, Taylor PM et al (1995) Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 151:1907\u20131914","journal-title":"Am J Respir Crit Care Med"},{"key":"20_CR71_20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0740-5472(93)90042-Z","volume":"10","author":"LT Kozlowski","year":"1993","unstructured":"Kozlowski LT, Henningfield JE, Keenan RM et al (1993) Patterns of alcohol, cigarette, and caffeine and other drug use in two drug abusing populations. J Subst Abuse Treat 10:171\u2013179","journal-title":"J Subst Abuse Treat"},{"key":"20_CR72_20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0741-8329(00)00101-4","volume":"21","author":"D Kunin","year":"2000","unstructured":"Kunin D, Gaskin S, Rogan F et al (2000) Caffeine promotes ethanol drinking in rats. Examination using a limited-access free choice paradigm. Alcohol 21:271\u2013277","journal-title":"Alcohol"},{"key":"20_CR73_20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0278-5846(95)00012-K","volume":"19","author":"H Kuribara","year":"1995","unstructured":"Kuribara H (1995) Caffeine enhances acute stimulant effect of morphine but inhibits morphine sensitization when assessed by ambulation of mice. Prog Neuropsychopharmacol Biol Psychiatry 19:313\u2013321","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"20_CR74_20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1254\/jjp.59.393","volume":"59","author":"H Kuribara","year":"1992","unstructured":"Kuribara H, Tadokoro S (1992) Caffeine does not effectively ameliorate, but rather may worsen the ethanol intoxication when assessed by discrete avoidance in mice. Jpn J Pharmacol 59:393\u2013398","journal-title":"Jpn J Pharmacol"},{"key":"20_CR75_20","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1046\/j.1460-9568.2000.00179.x","volume":"12","author":"A Kuzmin","year":"2000","unstructured":"Kuzmin A, Johansson B, Semenova S et al (2000) Differences in the effect of chronic and acute caffeine on self-administration of cocaine in mice. Eur J Neurosci 12:3026\u20133032","journal-title":"Eur J Neurosci"},{"key":"20_CR76_20","first-page":"146","volume":"93","author":"GL Lambrecht","year":"1993","unstructured":"Lambrecht GL, Malbrain ML, Chew SL et al (1993) Intranasal caffeine and amphetamine causing stroke. Acta Neurol Belg 93:146\u2013149","journal-title":"Acta Neurol Belg"},{"key":"20_CR77_20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0091-3057(95)00066-6","volume":"52","author":"CE Lau","year":"1995","unstructured":"Lau CE, Falk JL (1995) Dose-dependent surmountability of locomotor activity in caffeine tolerance. Pharmacol Biochem Behav 52:139\u2013143","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR78_20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02246346","volume":"126","author":"CE Lau","year":"1996","unstructured":"Lau CE, Wang J (1996) Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics. Psychopharmacology 126:115\u2013124","journal-title":"Psychopharmacology"},{"key":"20_CR79_20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0022-3565(24)36703-5","volume":"281","author":"CE Lau","year":"1997","unstructured":"Lau CE, Wang Y, Falk JL (1997) Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine. J Pharmacol Exp Ther 281:1013\u20131029","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR80_20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0376-8716(97)01362-8","volume":"45","author":"NP Lekka","year":"1997","unstructured":"Lekka NP, Paschalis C, Beratis S (1997) Nicotine, caffeine and alcohol use in high- and low-dose benzodiazepine users. Drug Alcohol Depend 45:207\u2013212","journal-title":"Drug Alcohol Depend"},{"key":"20_CR81_20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","volume":"98","author":"F Leri","year":"2003","unstructured":"Leri F, Bruneau J, Stewart J (2003) Understanding polydrug use: review of heroin and cocaine co-use. Addiction 98:7\u201322","journal-title":"Addiction"},{"key":"20_CR82_20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","volume":"90","author":"SC Licata","year":"2008","unstructured":"Licata SC, Rowlett JK (2008) Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav 90:74\u201389","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR84_20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0376-8716(97)00133-6","volume":"49","author":"A Liguori","year":"1997","unstructured":"Liguori A, Hughes JR, Goldberg K et al (1997) Subjective effects of oral caffeine in formerly cocaine-dependent humans. Drug Alcohol Depend 49:17\u201324","journal-title":"Drug Alcohol Depend"},{"key":"20_CR83_20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0376-8716(00)00196-4","volume":"63","author":"A Liguori","year":"2001","unstructured":"Liguori A, Robinson JH (2001) Caffeine antagonism of alcohol-induced driving impairment. Drug Alcohol Depend 63:123\u2013129","journal-title":"Drug Alcohol Depend"},{"key":"20_CR85_20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature00817","volume":"418","author":"M Lindskog","year":"2002","unstructured":"Lindskog M, Svenningsson P, Pozzi L et al (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418:774\u2013778","journal-title":"Nature"},{"key":"20_CR86_20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/FBP.0b013e3282fe8888","volume":"19","author":"P Maccioni","year":"2008","unstructured":"Maccioni P, Pes D, Carai MA et al (2008) Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Behav Pharmacol 19:197\u2013209","journal-title":"Behav Pharmacol"},{"key":"20_CR87_20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1037\/1064-1297.14.4.450","volume":"14","author":"CA Marczinski","year":"2006","unstructured":"Marczinski CA, Fillmore MT (2006) Clubgoers and their trendy cocktails: implications of mixing caffeine into alcohol on information processing and subjective reports of intoxication. Exp Clin Psychopharmacol 14:450\u2013458","journal-title":"Exp Clin Psychopharmacol"},{"key":"20_CR88_20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/FTD.0b013e31803257ed","volume":"29","author":"I Mart\u00edn","year":"2007","unstructured":"Mart\u00edn I, L\u00f3pez-V\u00edlchez MA, Mur A et al (2007) Neonatal withdrawal syndrome after chronic maternal drinking of mate. Ther Drug Monit 29:127\u2013129","journal-title":"Ther Drug Monit"},{"key":"20_CR89_20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1360-0443.2005.00944.x","volume":"100","author":"SE McCabe","year":"2005","unstructured":"McCabe SE, Knight JR, Teter CJ (2005) Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100:96\u2013106","journal-title":"Addiction"},{"key":"20_CR90_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nucmedbio.2007.08.005","volume":"35","author":"PN McCormick","year":"2008","unstructured":"McCormick PN, Kapur S, Seeman P et al (2008) Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo. Nucl Med Biol 35:11\u201317","journal-title":"Nucl Med Biol"},{"key":"20_CR91_20","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00007611-198809000-00006","volume":"81","author":"JD McGowan","year":"1988","unstructured":"McGowan JD, Altman RE, Kanto WP (1988) Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J 81:1092\u20131094","journal-title":"South Med J"},{"key":"20_CR92_20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2005.08.006","volume":"50","author":"R McNamara","year":"2006","unstructured":"McNamara R, Kerans A, O'Neill B et al (2006) Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (\u201cEcstasy\u201d) and MDA (\u201cLove\u201d). Neuropharmacology 50:69\u201380","journal-title":"Neuropharmacology"},{"key":"20_CR93_20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jadohealth.2008.03.003","volume":"43","author":"KE Miller","year":"2008","unstructured":"Miller KE (2008) Energy drinks, race, and problem behaviors among college students. J Adolesc Health 43:490\u2013497","journal-title":"J Adolesc Health"},{"key":"20_CR94_20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0091-3057(81)90131-3","volume":"14","author":"HE Modrow","year":"1981","unstructured":"Modrow HE, Holloway FA, Carney JM (1981) Caffeine discrimination in the rat. Pharmacol Biochem Behav 14:683\u2013688","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR95_20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(88)90298-3","volume":"459","author":"GK Mumford","year":"1988","unstructured":"Mumford GK, Neill DB, Holtzman SG (1988) Caffeine elevates reinforcement threshold for electrical brain stimulation: tolerance and withdrawal changes. Brain Res 459:163\u2013167","journal-title":"Brain Res"},{"key":"20_CR96_20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0149-7634(98)00050-5","volume":"23","author":"A Nehlig","year":"1999","unstructured":"Nehlig A (1999) Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev 23:563\u2013576","journal-title":"Neurosci Biobehav Rev"},{"key":"20_CR97_20","doi-asserted-by":"crossref","DOI":"10.1201\/9780203618851","volume-title":"Coffee, tea chocolate and the brain","author":"A Nehlig","year":"2004","unstructured":"Nehlig A (2004) Dependence upon coffee and caffeine: an update. In: Nehlig A (ed) Coffee, tea chocolate and the brain. CRC, Boca Raton"},{"key":"20_CR98_20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-8993(99)02480-4","volume":"858","author":"A Nehlig","year":"2000","unstructured":"Nehlig A, Boyet S (2000) Dose-response study of caffeine effects on cerebral functional activity with a specific focus on dependence. Brain Res 858:71\u201377","journal-title":"Brain Res"},{"key":"20_CR99_20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0091-3057(93)90299-9","volume":"44","author":"O Nikodijevi\u0107","year":"1993","unstructured":"Nikodijevi\u0107 O, Jacobson KA, Daly JW (1993) Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol Biochem Behav 44:199\u2013216","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR100_20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1553-2712.2008.00085.x","volume":"15","author":"MC O'Brien","year":"2008","unstructured":"O'Brien MC, McCoy TP, Rhodes SD et al (2008) Caffeinated cocktails: energy drink consumption, high-risk drinking, and alcohol-related consequences among college students. Acad Emerg Med 15:453\u2013460","journal-title":"Acad Emerg Med"},{"key":"20_CR101_20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00008877-199306000-00006","volume":"4","author":"AH Oliveto","year":"1993","unstructured":"Oliveto AH, Bickel WK, Hughes JR et al (1993) Pharmacological specificity of the caffeine discriminative stimulus in humans: effects of theophylline, methylphenidate and buspirone. Behav Pharmacol 4:237\u2013246","journal-title":"Behav Pharmacol"},{"key":"20_CR102_20","first-page":"207","volume":"9","author":"AH Oliveto","year":"1998","unstructured":"Oliveto AH, McCance-Katz E, Singha A et al (1998) Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav Pharmacol 9:207\u2013217","journal-title":"Behav Pharmacol"},{"key":"20_CR103_20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1037\/1064-1297.9.1.91","volume":"9","author":"KA Perkins","year":"2001","unstructured":"Perkins KA, Fonte C, Ashcom J et al (2001) Subjective responses to nicotine in smokers may be associated with responses to caffeine and to alcohol. Exp Clin Psychopharmacol 9:91\u2013100","journal-title":"Exp Clin Psychopharmacol"},{"key":"20_CR104_20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1037\/1064-1297.13.4.275","volume":"13","author":"KA Perkins","year":"2005","unstructured":"Perkins KA, Fonte C, Stolinski A et al (2005) The influence of caffeine on nicotine\u2019s discriminative stimulus, subjective, and reinforcing effects. Exp Clin Psychopharmacol 13:275\u2013281","journal-title":"Exp Clin Psychopharmacol"},{"key":"20_CR105_20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0091-3057(83)90269-1","volume":"18","author":"AD Potthoff","year":"1983","unstructured":"Potthoff AD, Ellison G, Nelson L (1983) Ethanol intake increases during continuous administration of amphetamine and nicotine, but not several other drugs. Pharmacol Biochem Behav 18:489\u2013493","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR106_20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0091-3057(97)00447-4","volume":"59","author":"KR Powell","year":"1998","unstructured":"Powell KR, Holtzman SG (1998) Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats. Pharmacol Biochem Behav 59:433\u2013438","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR107_20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1471-4159.2004.02761.x","volume":"91","author":"D Quarta","year":"2004","unstructured":"Quarta D, Borycz J, Solinas M et al (2004) Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-d-aspartate receptor stimulation. J Neurochem 91:873\u2013880","journal-title":"J Neurochem"},{"key":"20_CR108_20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0301-0082(02)00155-7","volume":"68","author":"JA Ribeiro","year":"2002","unstructured":"Ribeiro JA, Sebasti\u00e3o AM, de Mendon\u00e7a A (2002) Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68:377\u2013392","journal-title":"Prog Neurobiol"},{"key":"20_CR109_20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0091-3057(87)90614-9","volume":"26","author":"JD Roache","year":"1987","unstructured":"Roache JD, Griffiths RR (1987) Interactions of diazepam and caffeine: behavioral and subjective dose effects in humans. Pharmacol Biochem Behav 26:801\u2013812","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR110_20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neuropharm.2008.10.013","volume":"56","author":"S Rossi","year":"2009","unstructured":"Rossi S, De Chiara V, Musella A et al (2009) Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects. Neuropharmacology 56:590\u2013597","journal-title":"Neuropharmacology"},{"key":"20_CR111_20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0022-3565(25)09566-7","volume":"273","author":"CR Rush","year":"1995","unstructured":"Rush CR, Sullivan JT, Griffiths RR (1995) Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects. J Pharmacol Exp Ther 273:351\u2013358","journal-title":"J Pharmacol Exp Ther"},{"key":"20_CR112_20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.fbp.0000236274.18042.54","volume":"17","author":"H Sahraei","year":"2006","unstructured":"Sahraei H, Barzegari AA, Shams J et al (2006) Theophylline inhibits tolerance and sensitization induced by morphine: a conditioned place preference paradigm study in female mice. Behav Pharmacol 17:621\u2013628","journal-title":"Behav Pharmacol"},{"key":"20_CR113_20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(99)00613-5","volume":"383","author":"H Sahraei","year":"1999","unstructured":"Sahraei H, Motamedi F, Khoshbaten A et al (1999) Adenosine A(2) receptors inhibit morphine self-administration in rats. Eur J Pharmacol 383:107\u2013113","journal-title":"Eur J Pharmacol"},{"key":"20_CR114_20","first-page":"447","volume":"1","author":"S Schenk","year":"1990","unstructured":"Schenk S, Horger B, Snow S (1990) Caffeine preexposure sensitizes rats to the motor activating effects of cocaine. Behav Pharmacol 1:447\u2013451","journal-title":"Behav Pharmacol"},{"key":"20_CR115_20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s002130050246","volume":"130","author":"KJ Schuh","year":"1997","unstructured":"Schuh KJ, Griffiths RR (1997) Caffeine reinforcement: the role of withdrawal. Psychopharmacology 130:320\u2013326","journal-title":"Psychopharmacology"},{"key":"20_CR116_20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/syn.20595","volume":"63","author":"P Seeman","year":"2009","unstructured":"Seeman P (2009) Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals. Synapse 63:186\u2013192","journal-title":"Synapse"},{"key":"20_CR117_20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130050896","volume":"142","author":"M Shoaib","year":"1999","unstructured":"Shoaib M, Swanner LS, Yasar S et al (1999) Chronic caffeine exposure potentiates nicotine self-administration in rats. Psychopharmacology 142:327\u2013333","journal-title":"Psychopharmacology"},{"key":"20_CR118_20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/syn.20507","volume":"62","author":"N Simola","year":"2008","unstructured":"Simola N, Morelli M, Seeman P (2008) Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects. Synapse 62:394\u2013397","journal-title":"Synapse"},{"key":"20_CR119_20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00213-004-1898-3","volume":"176","author":"HJ Smit","year":"2004","unstructured":"Smit HJ, Gaffan EA, Rogers PJ (2004) Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology 176:412\u2013419","journal-title":"Psychopharmacology"},{"key":"20_CR120_20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.npp.1300415","volume":"29","author":"BF Sobel","year":"2004","unstructured":"Sobel BF, Sigmon SC, Griffiths RR (2004) Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers. Neuropsychopharmacology 29:991\u20131003","journal-title":"Neuropsychopharmacology"},{"key":"20_CR121_20","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1460-9568.2004.03682.x","volume":"20","author":"G Soria","year":"2004","unstructured":"Soria G, Casta\u00f1\u00e9 A, Berrendero F et al (2004) Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC. Eur J Neurosci 20:2203\u20132213","journal-title":"Eur J Neurosci"},{"key":"20_CR122_20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0091-3057(99)00049-0","volume":"64","author":"RD Spealman","year":"1999","unstructured":"Spealman RD, Barrett-Larimore RL, Rowlett JK et al (1999) Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64:327\u2013336","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR123_20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00210-003-0773-9","volume":"368","author":"L Stella","year":"2003","unstructured":"Stella L, De Novellis V, Vitelli MR et al (2003) Interactive role of adenosine and dopamine in the opiate withdrawal syndrome. Naunyn Schmiedebergs Arch Pharmacol 368:113\u2013118","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"20_CR124_20","first-page":"1","volume":"59","author":"IP Stolerman","year":"1993","unstructured":"Stolerman IP (1993) Components of drug dependence: reinforcement, discrimination and adaptation. Biochem Soc Symp 59:1\u201312","journal-title":"Biochem Soc Symp"},{"key":"20_CR125_20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/B:BEBM.0000020204.54037.be","volume":"136","author":"SK Sudakov","year":"2003","unstructured":"Sudakov SK, Rusakova IV, Medvedeva OF (2003) Effect of chronic caffeine consumption on changes in locomotor activity of WAG\/G and Fischer-344 rats induced by nicotine, ethanol, and morphine. Bull Exp Biol Med 136:563\u2013565","journal-title":"Bull Exp Biol Med"},{"key":"20_CR126_20","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1523\/JNEUROSCI.19-10-04011.1999","volume":"19","author":"P Svenningsson","year":"1999","unstructured":"Svenningsson P, Nomikos GG, Fredholm BB (1999) The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci 19:4011\u20134022","journal-title":"J Neurosci"},{"key":"20_CR127_20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0306-4603(94)90027-2","volume":"19","author":"JA Swanson","year":"1994","unstructured":"Swanson JA, Lee JW, Hopp JW (1994) Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict Behav 19:229\u2013256","journal-title":"Addict Behav"},{"key":"20_CR128_20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1471-4159.2006.03943.x","volume":"98","author":"E Tronci","year":"2006","unstructured":"Tronci E, Simola N, Carta AR et al (2006) Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons. J Neurochem 98:1078\u20131089","journal-title":"J Neurochem"},{"key":"20_CR129_20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1749-6632.1992.tb26022.x","volume":"654","author":"DB Tuazon","year":"1992","unstructured":"Tuazon DB, Suzuki T, Misawa M et al (1992) Methylxanthines (caffeine and theophylline) blocked methamphetamine-induced conditioned place preference in mice but enhanced that induced by cocaine. Ann N Y Acad Sci 654:531\u2013533","journal-title":"Ann N Y Acad Sci"},{"key":"20_CR130_20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-008-1214-8","volume":"200","author":"GB Varty","year":"2008","unstructured":"Varty GB, Hodgson RA, Pond AJ et al (2008) The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates. Psychopharmacology 200:393\u2013401","journal-title":"Psychopharmacology"},{"key":"20_CR131_20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/418734a","volume":"418","author":"JM Vaugeois","year":"2002","unstructured":"Vaugeois JM (2002) Signal transduction: positive feedback from coffee. Nature 418:734\u2013736","journal-title":"Nature"},{"key":"20_CR132_20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2125.2002.01681.x","volume":"54","author":"J Watson","year":"2002","unstructured":"Watson J, Deary I, Kerr D (2002) Central and peripheral effects of sustained caffeine use: tolerance is incomplete. Br J Clin Pharmacol 54:400\u2013406","journal-title":"Br J Clin Pharmacol"},{"key":"20_CR133_20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(99)00188-3","volume":"264","author":"SP Weisberg","year":"1999","unstructured":"Weisberg SP, Kaplan GB (1999) Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL\/6 mouse. Neurosci Lett 264:89\u201392","journal-title":"Neurosci Lett"},{"key":"20_CR134_20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00023210-200620030-00003","volume":"20","author":"K Wolff","year":"2006","unstructured":"Wolff K, Winstock AR (2006) Ketamine: from medicine to misuse. CNS Drugs 20:199\u2013218","journal-title":"CNS Drugs"},{"key":"20_CR135_20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0091-3057(98)00044-6","volume":"61","author":"R Young","year":"1998","unstructured":"Young R, Gabryszuk M, Glennon RA (1998) (-)Ephedrine and caffeine mutually potentiate one another\u2019s amphetamine-like stimulus effects. Pharmacol Biochem Behav 61:169\u2013173","journal-title":"Pharmacol Biochem Behav"},{"key":"20_CR136_20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0306-3623(96)00236-4","volume":"29","author":"MR Zarrindast","year":"1997","unstructured":"Zarrindast MR, Moghadamnia AA (1997) Adenosine receptor agents and conditioned place preference. Gen Pharmacol 29:285\u2013289","journal-title":"Gen Pharmacol"}],"container-title":["Handbook of Experimental Pharmacology","Methylxanthines"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-13443-2_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:41:25Z","timestamp":1740508885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-13443-2_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,19]]},"ISBN":["9783642134425","9783642134432"],"references-count":136,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-13443-2_20","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-642-13443-2","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,19]]}}}